Published in TB and Outbreaks Week, May 11th, 1998
A report presented at the 1998 Society for Pediatric Research Annual Meeting shows that children given the new vaccine developed anti-influenza antibodies in their nasal secretions.
Influenza epidemics occur yearly and are an important cause of winter-time respiratory illness throughout the world. Infection rates are highest in young children, often exceeding 40 percent. A current vaccine is given by intramuscular injection and is not administered routinely to healthy children.
Vaccines work by stimulating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week